home / stock / dbvt / dbvt news


DBVT News and Press, DBV Technologies S.A. From 06/16/23

Stock Information

Company Name: DBV Technologies S.A.
Stock Symbol: DBVT
Market: NASDAQ
Website: dbvtechnologies.com

Menu

DBVT DBVT Quote DBVT Short DBVT News DBVT Articles DBVT Message Board
Get DBVT Alerts

News, Short Squeeze, Breakout and More Instantly...

DBVT - Monthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2023

Monthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2023 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris ISIN Code: FR ...

DBVT - DBV Technologies to Participate in Upcoming EAACI Congress 2023

Montrouge, France, June 8, 2023 DBV Technologies to Participate i n Upcoming EAACI Congress 2023 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced upcoming particip...

DBVT - TIGR, APLS and LMFA among pre-market losers

2023-05-16 08:30:17 ET Modular Medical ( MODD ) -24% . Eloxx Pharmaceuticals ELOX -22% after Q1 earning release . LM Funding America ( LMFA ) -18% . Horizon Therapeutics Public Limited Company HZNP -18% reports FTC preparing suit to block Amgen de...

DBVT - Why Shares of DBV Technologies Jumped Thursday

2023-05-11 15:31:03 ET Shares of DBV Technologies (NASDAQ: DBVT) were up 14.5% early Thursday afternoon after the New England Journal of Medicine published phase 3 data on DBV's trial on its peanut allergy therapy for children aged one to three. The biotech company's shares ...

DBVT - WW, CDNA and DBVT are among after hour movers

2023-05-10 18:18:51 ET Gainers: Purple Innovation ( PRPL ) +25% . DBV Technologies ( DBVT ) +24% . KLX Energy Services Holdings ( KLXE ) +23% . Digimarc Corporation ( DMRC ) +18% . Applovin Corporation ( APP ) +13% . Losers...

DBVT - DBV Technologies Announces New England Journal of Medicine Publication of Phase 3 EPITOPE Trial Data Evaluating Viaskin(TM) Peanut in Toddlers

Montrouge, France, May 10, 2023 DBV Technologies Announces New England Journal of Medicine Publication of Phase 3 EPITOPE Trial D ata E valuating Viaskin™ Peanut in Toddlers Th e New England Journal of Medicine (NEJM) pu...

DBVT - DBV Technologies GAAP EPS of -$0.22, revenue of $2.2M

2023-05-04 17:40:03 ET DBV Technologies press release ( NASDAQ: DBVT ): Q1 GAAP EPS of -$0.22. Revenue of $2.2M (-12.0% Y/Y). For further details see: DBV Technologies GAAP EPS of -$0.22, revenue of $2.2M

DBVT - DBV Technologies Reports First Quarter 2023 Financial Results

Montrouge, France, May 4, 2023 DBV Tech nolo gies Reports First Quarter 2023 Financial Results DBV closes Q1 2023 with cash and cash equivalents of $192.3 million . DBV Technologies (Euronext: DBV – ISIN: FR0010417345 ...

DBVT - VUZI, CZOO and DBVT are among pre market gainers

2023-04-28 08:29:31 ET TOP Financial Group  ( TOP ) +272% brokerage TOP Financial sees stock soar 195%. AGBA Group Holding ( AGBA ) +75% . Golden Sun Education Group  ( GSUN ) +63% . Intelligent Living Application  ( ILAG ) +59%...

DBVT - DBV Technologies Outlines Regulatory Path for Viaskin Peanut in Children 1 - 3 Years After Receiving Pre-BLA Responses from FDA

Montrouge, France, April 19, 2023 D BV Technologies Outlin es Regulatory Path for Viaskin Peanut in Children 1 – 3 Years After Receiving Pre-BLA Responses from FDA The FDA confirmed that the Company’s Phase 3 EPITOPE study met the pre-specif...

Previous 10 Next 10